Oncompass Overview
- Founded
-
2003

- Status
-
Private
- Employees
-
50

- Latest Deal Type
-
2ndary - Private
Oncompass General Information
Description
Provider of therapeutic information services intended to provide precision oncology and cancer therapy information. The company's services identify the mutant cancer genes in the tumor and pinpoint the available targeted therapies, provide information on when and where targeted therapies are available, enabling oncologists to integrate targeted therapies into their personalized treatment strategy and help strategize a treatment plan.
Contact Information
Website
oncompassmedicine.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Media and Information Services (B2B)
Other Industries
Biotechnology
Primary Office
- Einsiedlerstrasse 23
- 8834 Schindellegi
- Switzerland
+41 044 000 00 00
Oncompass Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Secondary Transaction - Private | 01-Sep-2021 | 00000 | Completed | Generating Revenue | ||
2. Later Stage VC | 09-May-2012 | 00000 | 00000 | Completed | Generating Revenue | |
1. Capitalization | Completed | Startup |
Oncompass Patents
Oncompass Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200098477-A1 | System and method for adaptive medical decision support | Pending | 24-Dec-2014 | 000000000 | 0 |
US-20160224760-A1 | System and method for adaptive medical decision support | Inactive | 24-Dec-2014 | ||
EP-3238111-A1 | System and method for adaptive medical decision support | Pending | 24-Dec-2014 | G16H50/50 | 0 |
Oncompass Executive Team (9)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Istvan Petak Ph.D | Co-Founder, Chief Executive Officer & Chief Scientific Officer | ||
Attila Mézes | Chief Financial Officer | ||
Elvira Kubik | Head, Communications |